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The CIDI is a fully standardised, structured interview for the assessment of psychiatric disorders 
according to DSM-II-R and proposed ICD-10 criteria. The development of this interview has been the 
collaborative effort of researchers from 18 sites around the world. In a field trial to test the cross-
cultural acceptability and reliability of the questions, there was found to be high acceptance and 
excellent reliability for the substance use questions, problems with the lengthy alcohol section, and 
difficulties translating relevant substance use concepts into different languages. There is therefore 
room for further improvement in the substance-related questions. There proved to be differences 
between ICD-10 and DSM-III-R regarding substance abuse and dependence disorders.   
 
 
 
The Composite International Diagnostic Interview (CIDI) Core Version 1.0 (World Health 
Organization, 1987) is a fully standardised diagnostic interview for the assessment of 
psychiatric disorders which allows their classification according to DSM-III-R criteria 
(American Psychiatric Association, 1987) and ICD-10 (World Health Organization, 
1989a).The collaborative efforts to develop this instrument have been made possible by the 
World Health Organization (WHO) and the US Alcohol, Drug Abuse, and Mental Health 
Administration (ADAMHA) Joint Project on Diagnosis and Classification of Mental 
Disorders, and Alcohol and Drug-Related Problems. This is one product of the efforts 
initiated in 1980when the WHO/ADAMHA Joint Project began to support the development of 
a family of instruments for psychiatric assessment.  
 
The CIDI is an epidemiological instrument that allows non-clinician interviewers to ask 
questions in a highly standardised fashion, and to elicit answers which can be combined by 
computer to produce diagnoses according to the published criteria of different diagnostic 
systems. The CIDI Core Version 1.0 (hereafter referred to as the CIDI-Core) covers two of 
these diagnostic systems, ICD-10 and DSM-III-R for a subset of diagnoses.  
 
The original substance abuse and dependence sections of the CIDI came from the Diagnostic 
Interview Schedule (DIS; Robins et al, 1981); they assess the abuse of and dependence on 
tobacco, alcohol, cannabis, barbiturates and tranquillisers, amphetamines, cocaine, heroin and 
other opiates, phencycidine (PCP) and other hallucinogens and inhalants according to the 
DSM systems, the Feighner criteria (Feighner et al, 1972), the Renard Diagnostic Interview 
(RDI; Heizer et al, 1981) and Edwards Gross criteria (Edwards & Gross, 1976). With new 
developments in the nomenclature of the DSM and ICD systems, the WHO/ADAMHA Joint 
Project appointed a task force on alcohol- and drug-related disorders which suggested that the 
content and format of the substance use sections be revised to accommodate the classification 
changes. The task force also recommended adding: (a) symptom specific onset and recency 
questions to assess the natural history of substance abuse; (b) sections on the specific 
withdrawal symptoms and physical, social and psychological consequences for each drug; and 
(c) quantity/frequency questions to assess the severity of the dependence syndrome. Questions 
were developed to cover these areas; however, it was apparent that the application of an 
optimal version would be too detailed to be included in the CIDI-Core where a substance use 
disorder was just one among many psychiatric disorders covered, so this lengthier version was 
kept as a separate instrument - the CIDI Substance Abuse Module (SAM; Robins et al, 1990).  
 
The symptom questions in the SAM were field tested for inter-rater reliability in St Louis and 
were found to have excellent one-week retest reliability among substance abusers in treatment 
(Cottler et al, 1991). Thus, the SAM questions influenced an early version of the CIDI-Core. 
An international sub committee was formed to suggest further refinements to the CIDI-Core 
and these changes were then pre tested as part of the 1988 wave I CIDI-Core field trial in 18 
sites around the world.  
 
The main purpose of the field trial was to assess the CIDI-Core in a variety of research 
settings and cultures. The reliability and acceptability of the psychiatric symptom questions 
and diagnoses, other than those pertaining to substance use disorders, were found to be 
reliable and acceptable (see previous paper, this issue). The present paper describes the results 
of the CIDI field trial in terms of the acceptability of the substance questions in various 
cultures, the inter-rater reliability for these questions, and difficulties in translating relevant 
words and concept into different languages. Further suggestions for improvements are 
discussed. In addition, analyses have been done which assess system differences between 
ICD-l0 and DSM-III-R substance abuse and dependence disorders.  
 
Method  
 
The CIDI-Core field trials, including sample characteristics, are described in detail in the 
previous paper (this issue, pp. 645-653). Briefly, 590 subjects from 18 centres around the 
world participated in the first wave, which began in spring 1988. At each site a minimum of 
25 persons were interviewed. At six sites the subjects were hospital in-patients; at 11 sites 
they were hospital out-patients (in Minneapolis there were both in- and out-patients). One site 
sampled those enrolled with a health maintenance organisation and another recruited patients 
from a general practice.  
 
The principal investigators from each site underwent a one-week training course in Munich. 
The original CIDI-Core was written in English. Strict back-translation methods were followed 
by each centre for translating both interviews and training materials. The principal 
investigators then trained the 53 clinicians and 55 non clinician interviewers who participated 
in these trials. Each subject was independently rated by an interviewer and an observer. While 
the interviewer queried the respondent using the CIDI-Core, the observer silently documented 
discrepancies, or questionable areas for clarification with the respondent at the end of the 
interview.  
 
In developing the section on substance use, care was taken to minimise the confrontational 
nature of questions on drug abuse. For example, questions on lifetime tobacco use were 
placed near the beginning of the psychiatric interview to provide an easy introduction, since 
this behaviour is common, freely admitted, and is not considered threatening by respondents. 
In contrast, the alcohol and drug sections were placed nearer the end of the interview, after the 
sections on somatisation, affective, and anxiety disorders, so they could be asked after rapport 
had been achieved.  
 
‘Skip-outs’ were provided appropriately; for example, questions about tobacco use were 
terminated if a respondent reported never smoking daily for a month or more. The questions 
about alcohol were skipped for respondents who denied ever having had a drink and the drug 
questions skipped if no drug had ever been used six or more times.  
 
Two interview documents per subject were produced - one recorded by the interviewer and 
one by the observer. Only the interviewer's coding of the responses is used for the descriptive 
analyses, while for reliability statistics, the observer's record of responses is compared with 
the interviewer's. The kappa statistic was used to analyse the agreement between raters on all 
responses which are dichotomous. Diagnostic algorithms developed at Washington University 
in St Louis were used to determine DSM-III-R and ICD-10 psychoactive substance use 
diagnoses.  
 
The length of the substance abuse section prohibits the publication of these questions here; 
however, the questionnaire can be obtained by writing to the authors. The substance abuse 
sections differed from other sections in that the age of onset and recency of each symptom is 
ascertained. In other sections, a summary age of onset and recency is ascertained for the first 
and last time any symptom from a group of symptoms occurred.  
 
Results  
 
Nine of the 590 subjects interviewed had data missing from the substance abuse section, and 
so the analyses below relate to 581 subjects.  
 
Acceptability  
 
The most common complaint was that the substance abuse sections were still unbearably long 
within the context of a full psychiatric diagnostic interview. The onset questions for 
individual positive symptoms added considerably to the interview administration time. This 
complaint was heard from every site and documented in the ratings completed by each 
interviewer at the end of the interview session. The acceptance ratings of the alcohol, drug 
and tobacco section are shown in Table1.The tobacco section received scores indicative of 
overall acceptance, although several sites - in the Netherlands, Australia, Portugal and Italy - 
questioned the inclusion of tobacco use in a psychiatric interview. The alcohol section, 
although shorter than the drug section, was perceived to be slightly longer than the drug 
section. This was perhaps because it had to be asked of many more persons, both because 
alcohol use is more common than drug use and because the alcohol section did not allow a 
skip for persons whose experience with alcohol was minimal: only respondents who 
volunteered that they had never had a drink were excused. A unanimous decision was later 
reached to exclude persons with minimal drinking histories. The revised CIDI-Core now 
allows a skip for persons who have never had “as many as 12 alcoholic drinks in any one 
year” and persons who have never had “at least 12 drinks in their lifetime”.  
 
None of the subjects who had not drunk as regularly as once a month or had never had four 
drinks in four hours met diagnostic criteria. More than a quarter (28%) of the sample could 
have skipped the section on the basis of these two questions without losing a single case of 
abuse or dependence. Another 6% of the sample could have skipped the section after a brief 
set of questions asking about drinking heavily (having seven drinks once a week for several 
months), drinking more than intended to, being preoccupied with drinking, giving up 
activities for drink and having physical, psychological or social problems from drinking. 
These data suggest that an appropriate quantity/frequency question may function as an 
efficient screen.  
 
Other changes to shorten the interview included reducing the number of questions asked to 
assess a single alcohol criterion, combining recency and onset questions for criteria assessed 
by multiple questions, and reducing the number of drug categories by combining tranquillisers 
with barbiturates in a sedative section and heroin with other opiates for an opiate category.  
 
Although the length of the substance abuse section was a problem at all sites, other problems 
were site specific. These were not unexpected, since cultures differ in attitudes towards 
substance use and in defining when use becomes abuse. For example, collaborators 
experienced a number of difficulties with the operationalisation of substance abuse and 
dependence criteria. One centre noted that binge drinking (staying drunk for two days or 
longer) is acceptable behaviour during ‘official festivals’. To make this question culturally 
appropriate, exclusionary criteria were added for binges restricted to these occasions. Several 
sites reported that some respondents were offended by being asked about legal and illegal 
drugs in the same question and recommended a distinction between them in the interview so 
that persons who used prescribed medications could admit this without the stigma attached to 
illicit drug use. Thus, separate categories were provided for prescribed and illicit drugs.  
 
Interviewers, respondents and translators in some sites noted problems with the translation of 
certain words in the interview. For example, the word ‘drink’ frequently used as a noun and a 
verb) was not clear to all respondents, since it does not mean an ‘alcoholic beverage’ in some 
cultures, and in others implies whisky but not beer or wine. Measuring intake was problematic 
because there are cultures which have no standard ‘drink’ in terms of alcohol content and 
strength. Additionally, the words ‘high’, tolerant’ and ‘dependent’ used throughout the 
interview, are either not translatable or difficult to translate into some languages.  
 
Many of the differences noted are unavoidable for substance disorders, which can arise as a 
consequence to a variety of substances. Thus, the Joint Project Task Force recommended that 
investigators should know their local customs surrounding drinking and drug use including 
the usual volume drunk and the alcohol content by volume, and that translations be faithful to 
the interview's intent rather than to its original wording. The task force also suggested that the 
interviewers be well trained on the intent of all questions.  
 
Rates of drug use and symptoms  
 
In spite of cultural differences, there was an amazing similarity across sites in the types of 
drugs used and symptoms reported. All centres asked the tobacco, alcohol and drug questions 
in the CIDI-Core. In all sites except Beijing, at least one respondent reported using drugs at 
some time in his/her life. Most subjects reported smoking daily for a month or more at some 
time in their life (56.3%). Over a quarter (25.1%) of the sample met criteria for lifetime heavy 
drinking (defined as ever drinking the equivalent of 20 drinks of liquor in one day, daily 
drinking of at least seven drinks for two weeks, or two months of drinking at least seven 
drinks a week). A quarter of the entire sample (n = 147) reported never drinking; these 
persons are excluded from the remainder of the alcohol analyses. Illicit use of drugs six or 
more times was reported by only 14% of the sample. Marijuana was the most commonly used 
drug (12%), followed by tranquillisers, barbiturates and amphetamines (each 5%). Cocaine 
use was reported by 4% of the sample, hallucinogens and opioids were less commonly 
reported (3% each). Inhalants and PCP were the least commonly used (1% each).  
 
Common symptoms relating to substance use are shown in Table 2. Experiencing emotional 
problems from drugs, developing tolerance to drugs, and using larger amounts of drugs than 
intended were each reported by nearly half the persons reporting any use of drugs six or more 
times. The use of the same criteria for abuse and dependence for all substances allows us to 
report the proportion positive for these symptoms among all drinkers and among those who 
had been heavy drinkers (Table2). Among both types of drinkers, social problems and 
tolerance were the most common symptoms reported. Heavy drinkers were at least twice as 
likely to report experiencing any symptom.  
 
Reliability  
 
An additional purpose of the field trial was the evaluation of the reliability of diagnoses and 
of the specific questions used to make alcohol and drug abuse and dependence diagnoses. 
Kappa values in excess of 0.93 were obtained for agreement between observer and 
interviewer reports of lifetime use of these substances and over 0.94 for each of the symptoms 
in Table 2, indicating excellent reliability.  
 
Nosological comparisons  
 
Although not one of the goals of this field trial, these data offer an early opportunity to 
address differences in the way in which the alcohol and drug disorders are classified in DSM-
III-R and ICD-10. Comparisons are provided for the most commonly reported substances: 
alcohol, marijuana, opioids, and stimulant use. The comparisons exclude tobacco disorders 
because DSM-III-R and ICD-l0 criteria were not assessed in the CIDI-Core version used in 
the field trials. In Table 3, the number of persons who met DSM-III lifetime criteria is cross-
tabulated with the number who met lifetime criteria for an ICD-l0 diagnosis. Thus, for ICD-
10, three or more symptoms are necessary, but the requirement for these symptoms to occur 
together in one month or in previous 12 months is ignored.  
 
The comparisons for alcohol exclude the 147personswho never had a drink. The comparisons 
for the remaining428 persons show that DSM-III-R has labelled 104 persons as dependent 
while ICD-10 has so labelled only 94. More persons (48) met criteria for ICD-l0 ‘harmful 
use’ than met criteria for DSM-III-R ‘abuse’ (35).Of the 35 persons in the DSM-III-R abuse 
category, 11were in the ICD-10 harmful use category, while 8 of the 94 labelled dependent in 
ICD-10 were labelled abusers according to DSM-III-R. The ICD-10 harmful use category has 
broader limits than the DSM-III-R abuse category. The kappa statistic for overall agreement 
for all alcohol disorder categories is in the good to excellent range (0.81).  
 
No respondent met ICD-10 criteria for marijuana, stimulant or opiate dependence, although 
17 persons were diagnosed with marijuana dependence and 12 diagnosed with stimulant 
dependence according to DSM-III-R criteria. However, for marijuana, as with alcohol, more 
persons met criteria for ICD-10 harmful use than for DSM-III-R abuse.  
 
The low kappa value for marijuana (0.48) indicates that diagnostic agreement between the 
two systems was not as good as for alcohol. The poor agreement (kappa = 0.46) for stimulants 
overall was due primarily to the lack of agreement for the dependence category. Opioid 
disorders were rare among persons who used opioids; furthermore, dependence criteria were 
not met for either of the diagnostic systems. The two systems' distributions of opioid abuse 
and harmful use were approximately equivalent (kappa= 0.82). The higher agreement for 
opioids (compared with other drugs) was probably due to the more severe consequences of 
these substances. At least for three commonly reported substances - alcohol, marijuana and 
stimulants - the CIDI Core questions which cover the DSM-III-R system seem to cast a wider 
net for dependence than the questions which cover the ICD-10 system.  
 
Discussion  
 
The substance use sections of the CIDI-Core were the sections most extensively revised as a 
result of the field trial. These revisions have reduced the length of the instrument and 
recognised cultural differences in patterns of substance use and language. Reliability 
presented no problem. Furthermore, because the criteria continue to evolve, a symbiotic 
relationship exists between criteria development and instrumentation, which guarantees 
continued change. As Robins (1989) and Cottler & Keating (1990) have demonstrated, this 
relationship is particularly strong with substance abuse and dependence because a lack of 
clarity in diagnostic concepts is sometimes only realised once the operationalisation of these 
concepts is attempted. The difficulty encountered is intensified when the questions and 
concepts must be translated into a variety of languages and understood by persons from many 
cultures.  
 
In spite of the difficulties, the CIDI-Core substance use sections, as they appeared during our 
first field effort, have been found to be acceptable and highly reliable. The field trial 
confirmed the authors' suspicions that the sections were too long. Incorporating a skip 
instruction early in the alcohol section should help solve the problem. Moreover, as with other 
diagnostic sections of the CIDI-Core, revisions have been instituted by the task force to make 
the interview shorter and more palatable.  
 
Even though the CIDI-Core has been revised, we have no reason to believe that the reliability 
of these new, revised questions will be poorer than that reported for these original questions, 
since the changes were in response to problem areas and the changes were well thought out, 
and pre-tested in certain instances. However, it must be emphasised that the newest changes 
have not undergone rigorous pilot testing. The plans for a further set of international studies 
which assess test-retest reliability and diagnostic validity are underway now, especially 
focused on alcohol and drug disorders.  
 
The investigators were not surprised to find excellent reliability with the substance abuse 
sections since the other diagnostic sections were equally reliable and many of the same 
questions had been found to have excellent one-week test-retest reliability in a population of 
substance abusers in St Louis (Cottler et al, 1989). But, additionally, because the interviewers 
and observers were paired together in the same room, the field trial methods may have been 
biased in favour of good reliability. However, this cost-efficient interviewer/observer design 
was chosen instead of the more costly test-retest method. Although not unexpected, the 
favourable results obtained are welcome, especially given the hetero geneous samples and 
different cultures studied.  
 
The ability to compare diagnostic systems on an international level is one of the most 
promising and fascinating aspects of the CIDI-Core and the WHO/ADAMHA Joint Project. 
Our early nosological comparisons indicate either that DSM-III-R's dependence criteria are 
broader than ICD- 10's, or perhaps that our questions which cover the ICD-b need 
improvement. Perhaps for alcohol, stimulants and marijuana, the diagnostic assignments of 
‘caseness’ are different because the DSM-III-R concept of dependence includes social 
impairment, which ICD-10's does not. However, these early comparisons should not be 
interpreted as a failure of the systems to agree but as an indication of the type of analyses 
which can be performed on data collected by a structured instrument of this type. We must 
remember that the ICD system has been in flux since these questions were written and the 
DSM system is in the process of being revised. These changes in criteria will necessitate 
further changes in CIDI questions, which will lead to further pre-testing.  
 
These important comparisons should be replicated by other investigators and with larger 
samples. Additionally, work needs to be done to evaluate the nomenclatures, and the 
differences and similarities between the classification systems for other categories of 
substances. These findings add to the preliminary findings from a study of drug abusers in St 
Louis which revealed that for many psychoactive substances, DSM-III-R labels a larger 
proportion of users as dependent than the earlier DSM-III system (Cottler et al,1989).  
 
The difficult task is behind us. Producing an instrument which can be used comfortably and 
reliably in so many different cultures is a tremendous achievement for psychiatric 
epidemiology and clinical psychiatry. Investigators from all over the world can now use the 
CIDI family of instruments to measure the problems associated with drug and alcohol use 
reliably and most importantly to make communication of substance abuse problems between 
many nations possible.   
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